KENDALLVILLE Eighteen-month-old Omarion Jordan plays with his toys in his Kendallville home under the watchful eye of his mother, Kristin Simpson, and the family dog. He's wiggly and active, with no hint of the rare genetic disease that could have taken his life before age2.
Omarion has a rare genetic disorder called severe combined immunodeficiency syndrome, SCID for short and better known as the bubble boy disease made famous in a 1976 television movie starring John Travolta as well as an episode of the 1990s sitcom Seinfeld. The disease affecting 40 to 100 American newborns each year makes them extremely vulnerable to infections, which left untreated, kills most children before they turn two. Simpson said SCID is caused by a random gene mutation on the maternal side. She said she has no family history that would indicate it was present in family members.
Omarion was born normally, but began to have skin infection symptoms before he was 3-months-old, she said. Doctors thought he had an extreme case of eczema or cradle cap.
Simpson said everything changed when Omarion got his 3-month vaccinations.
He had a bad reaction. He had no immune system to react with the vaccine, she said. He was covered in a green, pus-like substance.
Simpson took Omarion to the emergency room twice, but was sent home. She then made an appointment with her pediatrician, not knowing then that it would be months before she saw her apartment again.
The pediatrician sent us right to the hospital, Simpson said. It was 11/2 weeks to clear the infection. I had to drop everything. I never came back (to the apartment) after that morning.
Doctors sent Omarion and his mother on a four-hour ambulance ride to Cincinnati Children's Hospital for tests. There, Simpson learned that the standard treatment for SCID was a bone marrow transplant. When a two-month search for a bone marrow match came up empty, doctors suggested another route.
There was a trial at St. Jude (Children's Hospital) for gene therapy and we were given the option, Simpson said. We were flown to St. Jude's on a private jet.
The experimental gene therapy used Omarion's own bone marrow, altered to correct the missing gene. The altered bone marrow is transplanted back into Omarion's body, carried by an HIV virus with all the harmful cells removed.
It's like a car, Simpson said. They take out the harmful elements and use the virus as a carrier for the altered gene.
Experimental gene therapy comes with both reward and risk. The treatment could be a breakthrough cure for Omarion and other children affected by the gene mutation.
The risks include developing leukemia, which has happened to some patients in the small trial group, other unknown side effects and the enormous financial cost. Treatment costs run into the millions of dollars.
Gene therapies, while breaking new ground in fighting tough-to-cure ailments, are a cutting edge field of medicine, but also an exceptionally expensive one. For example, a gene therapy drug called Zolgensma is the most expensive drug ever approved in the United States, according to a Bloomberg Businessweek story about Omarion and the rise of gene therapies. A one-time infusion costs $2.1 million.
Omarion's case has received national media attention, including the story from Bloomberg Businessweek, which published a story June 5 about the balance of rapidly progressing gene therapy and its high cost, and other outlets including NBC News, WebMD.com and CNN Health.
Simpson is grateful that St. Jude's Children Hospital, the world's leader in the treatment of childhood diseases, has picked up the entire tab for Omarion's treatment.
Simpson said that at St. Jude, she and her mother were the only family members allowed inside Omarion's isolation room. Everyone else was fully masked and gowned. They were in the isolation room for months.
Omarion received his bone marrow transplant Dec. 20, 2018, and finally left the hospital in April. Omarion will have checkups every three months for the foreseeable future and an annual checkup for the rest of his life.
Today he's healthy, thanks to a cutting-edge gene therapy treatment, and a walking miracle.
- Patients with Severe Forms of Coronavirus Disease Could Offer Clues to Treatment - Howard Hughes Medical Institute - March 26th, 2020
- Clean your phone 'at least once a day,' medical experts say. Here's howwithout damaging the screen - CNBC - March 26th, 2020
- Castle Creek Biosciences Announces $75 Million Investment to Advance Development of Multiple Gene Therapy Candidates for Rare Diseases - Yahoo Finance - March 26th, 2020
- Bridging the gap study sequences Asian genomes to diversify genetic databases - University of Virginia The Cavalier Daily - March 26th, 2020
- Coronavirus Treatment: Hundreds of Scientists Scramble to Find One - The New York Times - March 26th, 2020
- AZ adds gene silencing tech to pipeline with Silence Therapeutics deal - - pharmaphorum - March 26th, 2020
- A coronavirus test can be developed in 24 hours. So why are some countries still struggling to diagnose? - CNN - March 26th, 2020
- Vycellix and Avectas Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies - BioSpace - March 26th, 2020
- Meet a superhero that fights breast cancer, neurofibromin - Baylor College of Medicine News - March 26th, 2020
- Twelve Women Who Have Shaped The History of the BioHealth Capital Region - BioBuzz - March 26th, 2020
- Study reveals gene therapy may help in treating cardiac disease - The Siasat Daily - March 26th, 2020
- Alnylam Pharmaceuticals and Gen Sign Distribution Agreement in Turkey for ONPATTRO (patisiran), the First-in-Class Gene-Silencing RNAi Therapeutic -... - March 26th, 2020
- Covid-19: Why testing takes time and what to expect - Daily Maverick - March 26th, 2020
- Gene editing might help restore extinct plants used as food, medicine and perfume thousands of years ago - Genetic Literacy Project - March 23rd, 2020
- A new AI system has enabled the discovery of a novel role for 'smell-sensing' genes in colon cancer - Healthcare IT News - March 23rd, 2020
- Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the US and Canada - PRNewswire - March 23rd, 2020
- Amicus Therapeutics Confirms Business Continuity, 2020 Strategic Priorities and Announces Proactive Efforts to Support Public Health Initiatives,... - March 23rd, 2020
- Genetron Health Contributes to China's First Expert Consensus Statement on the Standardized Clinical Application of NGS Testing for Oncology -... - March 23rd, 2020
- HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies -... - March 21st, 2020
- Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients | NDT - Dove Medical Press - March 21st, 2020
- Novel Discovery of "Hidden" Gene Within a Gene in Mammals - Technology Networks - March 21st, 2020
- Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic... - March 21st, 2020
- Fact check: Were elderly Italians left to die? And is socialized health care to blame? - USA TODAY - March 21st, 2020
- Why There Aren't Enough Coronavirus Tests in the U.S. - Popular Mechanics - March 21st, 2020
- AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome - Associated Press - March 21st, 2020
- CRISPR Used To Edit Genes Inside A Patient With A Rare Form Of Blindness : Shots - Health News - NPR - March 5th, 2020
- Gene and cell therapies continue growth in patients, financing, and costs - STAT - March 5th, 2020
- Editas and Allergan Make Gene-Editing History With First Treatment of Blindness Drug - The Motley Fool - March 5th, 2020
- A snapshot of the precision medicine landscape - MedCity News - March 5th, 2020
- Allergan and Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the... - March 5th, 2020
- Sysmex : and the Kobe City Eye Hospital Sign a Comprehensive Collaboration Agreement -Reinforcing Collaboration toward the Realization of Genomic... - March 5th, 2020
- Biochemical and structural cues of 3D-printed matrix synergistically direct MSC differentiation for functional sweat gland regeneration - Science... - March 5th, 2020
- GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery - Business Wire - December 13th, 2019
- Personalized CF Medicine to be Tested for Rare Genetic Defects in Europe - Cystic Fibrosis News Today - December 13th, 2019
- Experts Forum: Creating a cluster of innovation in Rochester - Finance and Commerce - December 13th, 2019
- Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing - GlobeNewswire - December 13th, 2019
- Care Coordination and Precision Medicine Improve Early Diagnoses - HealthPayerIntelligence.com - December 13th, 2019
- Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease - P&T... - December 13th, 2019
- Would you pay $2.1 million for one-off gene therapy? - Kalkine Media - December 13th, 2019
- The genetic mutation behind a new autoinflammatory disease - Pursuit - December 13th, 2019
- New Anti-Aging Clinical Trial Begins. For $1 Million, You Can Be a Participant. - Livescience.com - December 13th, 2019
- Updates from SABCS 2019: Detection and Screening, Immunotherapy Advances, and Therapy Resistance - On Cancer - Memorial Sloan Kettering - December 13th, 2019
- Researchers unfold genetic code that controls cell function and disease - BSA bureau - December 13th, 2019
- Our shockingly short lives without modern medicine revealed - Newshub - December 13th, 2019
- First look at CRISPR, Vertex gene-editing therapy hints at treatment potential - BioPharma Dive - November 23rd, 2019
- Applying AI and CRISPR to stem cells to improve regenerative medicine - FierceBiotech - November 23rd, 2019
- Will a Treatment for Alzheimer's Ever Be Found? - Columbia University Irving Medical Center - November 23rd, 2019
- This Mom Is Buying Mutant Mice From China To Find A Cure For Her Sons Rare Genetic Disease - BuzzFeed News - November 23rd, 2019
- These Scientists May Have Found a Cure for 'Bubble Boy' Disease - Smithsonian.com - November 23rd, 2019
- Calculating the Spatial Pattern of Gene Expression for the Entire Genome - Technology Networks - November 23rd, 2019
- Gene linked to Alzheimers disease plays indirect role in risk for... - ScienceBlog.com - November 23rd, 2019
- A Reflection On BTD And RMAT Designations - Pink Sheet - November 23rd, 2019
- Nature vs Nurture: What's Fueling the Obesity Epidemic? - Medscape - November 23rd, 2019
- Sniffing Out Cancer in Canines And Humans, Too - NC State News - November 23rd, 2019
- A Rare Genetic Disorder Turned These Siblings' Blood 'Milky' White - Livescience.com - November 23rd, 2019
- To Improve Public Health, Medicine Regulators Worldwide Should Collaborate, Remove Barriers to Sharing Information, Says New Report - National... - November 21st, 2019
- The Medicine Plant That Could Have Changed the World. - The National Interest Online - November 21st, 2019
- Consumer DNA Testing May Be the Biggest Health Scam of the Decade - Gizmodo - November 21st, 2019
- Genetically Modified Babies? Possible Within the Next Two Years, Scientists Claim - Nature World News - November 21st, 2019
- A 17-gene expression signature to distinguish patients who are likely to achieve long-term remissions following front-line FCR chemoimmunotherapy from... - November 21st, 2019
- UC Davis leads in innovative gene editing research with NIH grants - The Aggie - November 21st, 2019
- New research casts doubt on near reality of 'designer babies' - PRNewswire - November 21st, 2019
- Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis - BioSpace - November 21st, 2019
- Global Cancer Biomarkers Market, Forecast to 2026 - Emerging Economies & Personalized Medicine to Provide Ample Industry Opportunities -... - November 21st, 2019
- This miracle drug was designed and manufactured for just one person a 9-year-old Boulder girl - The Colorado Sun - November 21st, 2019
- Novartis' Zolgensma gene therapy study halted on animal safety concerns - STAT - October 31st, 2019
- Ruanne Vent-Schmidt: The blind and visually impaired can help researchers by getting their genes tested - Vancouver Sun - October 31st, 2019
- Obesity Is in the Genes - Scientific American - October 31st, 2019
- Soon, genetic testing for cancer treatment could match you with the perfect drug - NorthJersey.com - October 31st, 2019
- Alcohol intake and reduced brain volume: What explains the link? - Medical News Today - October 31st, 2019
- Genome Sequencing In NICU Can Speed Diagnosis Of Rare Inherited Diseases : Shots - Health News - NPR - October 31st, 2019
- Charting the evolution of diabetes research and care | Speaking of Medicine - PLoS Blogs - October 31st, 2019
- Huntington's Marked by Inflammation and Changes in Brain's Striatum Before Symptoms, Study Finds - Huntington's Disease News - October 31st, 2019
- Gene Lee: 5 Fast Facts You Need to Know - Heavy.com - October 31st, 2019
- Gene Expression Market to Reach USD 11.37 Billion by 2026 | Reports and Data - P&T Community - October 15th, 2019
- Gene therapy for Duchenne muscular dystrophy safely preserves muscle function - Penn: Office of University Communications - October 15th, 2019
- Global Neurodegenerative Disorder Therapeutics Market 2019-2024: Opportunities in Digital Biomarkers, Microbiome Therapeutics, Cell and Gene Therapy,... - October 15th, 2019
- Food As Medicine: What Biochemistry And Genetics Are Teaching Us About How To Eat Right - Forbes - October 15th, 2019
- Some cases of SIDS may have this genetic cause - Futurity: Research News - October 15th, 2019
- The 2019 Nobel Prize In Medicine: Here Is What Won The Award - Forbes - October 15th, 2019